Bayer Aspirin Extra Strength Plus Interactions
There are 343 drugs known to interact with Bayer Aspirin Extra Strength Plus (aspirin), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 51 are major, 247 are moderate, and 45 are minor.
- View all 343 medications that may interact with Bayer Aspirin Extra Strength Plus
- View Bayer Aspirin Extra Strength Plus alcohol/food interactions (2)
- View Bayer Aspirin Extra Strength Plus disease interactions (9)
Most frequently checked interactions
View interaction reports for Bayer Aspirin Extra Strength Plus (aspirin) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Advil (ibuprofen)
- amlodipine
- atorvastatin
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- diazepam
- folic acid
- furosemide
- gabapentin
- glyburide
- hydrochlorothiazide
- ibuprofen
- Lasix (furosemide)
- levothyroxine
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- lisinopril
- lutein
- metformin
- montelukast
- naproxen
- Neurontin (gabapentin)
- Plavix (clopidogrel)
- temazepam
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- vitamin e
Bayer Aspirin Extra Strength Plus alcohol/food interactions
There are 2 alcohol/food interactions with Bayer Aspirin Extra Strength Plus (aspirin).
Bayer Aspirin Extra Strength Plus disease interactions
There are 9 disease interactions with Bayer Aspirin Extra Strength Plus (aspirin) which include:
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Report options
More about Bayer Aspirin Extra Strength Plus (aspirin)
- Bayer Aspirin Extra Strength Plus consumer information
- Compare alternatives
- Reviews (4)
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
